Maynard Um
-
-
-
-
-
-
-
LENZ Therapeutics Inc (LENZ) PT Lowered to $26 at Citi
-
-
-
-
-
-
-
LENZ Therapeutics partners with Lunatus for VIZZ distribution in Middle East
-
-
-
-
-
-
-
LENZ Therapeutics Inc (LENZ) PT Raised to $56 at H.C. Wainwright
-
-
-
-
-
-
-
LENZ Therapeutics (LENZ) licenses LNZ100 eye drop to Théa for Canada market
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on LENZ Therapeutics Inc (LENZ)
-
-
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

